PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1882990
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1882990
The global automated endoscope reprocessors (AER) market continues to grow steadily as healthcare systems worldwide prioritize stricter infection control, standardized reprocessing procedures, and increased adoption of minimally invasive diagnostics. According to the report, the global AER market was valued at USD 697.7 million in 2024, is projected to reach USD 725.6 million in 2025, and is expected to climb to USD 1,006.4 million by 2032, reflecting a CAGR of 4.8% during the forecast period. In 2024, North America dominated the global market with a 49% share, supported by advanced healthcare infrastructure and high volumes of endoscopic procedures.
Automated endoscope reprocessors are essential devices used to clean and disinfect reusable endoscopes through automated high-level disinfection cycles. These systems ensure consistent sterilization outcomes, minimize human error, and help healthcare facilities protect patients from healthcare-associated infections (HAIs). With rising procedure volume and growing emphasis on infection prevention, AER adoption has become a fundamental part of hospital safety protocols.
Market Drivers
One of the strongest contributors to market growth is the increasing number of endoscopic procedures, driven by rising global incidence of gastrointestinal, pulmonary, and oncological disorders. According to NCBI data published in May 2024, over 17.7 million GI endoscopic procedures are performed annually in the U.S., highlighting the volume of devices that require efficient reprocessing. An aging global population also elevates demand, as older adults experience higher rates of chronic diseases requiring regular diagnostic examinations. This surge in procedures directly accelerates the need for advanced AER systems in hospitals and specialty clinics.
Market Restraints
Despite strong growth factors, a major challenge is the limited availability of skilled staff in low-income countries. Endoscope reprocessing requires specialized training to ensure compliance with infection control guidelines. As highlighted by the Royal Australian College of General Practitioners (RACGP) in June 2024, facilities must ensure staff are adequately trained-a requirement that is difficult and costly for many under-resourced settings. This skill gap leads some healthcare centers to rely on manual reprocessing methods, limiting AER penetration.
Market Opportunities
Emerging economies present substantial growth prospects. Rising awareness of HAIs, expanding hospital infrastructure, and increased investments in surgical and diagnostic services are boosting adoption. For example, in April 2025, Yashoda Hospitals in India launched a Center of Excellence for Robotic Neurosurgery and Neuro Endoscopy, highlighting the region's expansion in minimally invasive procedures. Government-funded modernization programs and increasing private sector investments further strengthen the long-term demand for cost-effective, compact AER systems designed for smaller facilities.
Market Challenges
One of the key barriers to broader adoption is the high initial investment associated with AER systems. Costs include the equipment itself, dedicated installation space, water filtration systems, ventilation, and ongoing purchases of disinfectants. Smaller clinics and hospitals often lack sufficient budgets, restricting their adoption. Higher maintenance costs and device servicing needs also elevate operational expenses, slowing market expansion in cost-sensitive regions.
Key Market Trends
Technological advancements are shaping new trends in the AER market. Healthcare providers are transitioning away from manual cleaning due to its inefficiency and higher risk of human error. AERs equipped with enhanced digital workflow integration, real-time data logging, and tracking systems are in growing demand. For example, Getinge's updated ED-Flow AER introduced in 2022 incorporated improved digital connectivity features. Strict guidelines from CDC, FDA, and ESGE are further encouraging facilities to adopt advanced, automated systems to ensure compliance and traceability.
North America
North America led the market in 2024 with USD 341.9 million. High endoscopy procedure rates and advanced infection control requirements drive regional demand. GI procedures alone account for over 68% of all endoscopic procedures in the U.S.
Europe
Europe ranked second in 2024, supported by strong regulatory standards, increasing healthcare budgets, and a shift toward standardized automated reprocessing.
Asia Pacific
Asia Pacific is expected to record the highest CAGR, fueled by rising nosocomial infection rates and rapid healthcare facility expansion. In India, 10-20% of patients experience hospital-acquired infections, pushing hospitals toward improved disinfection systems.
Latin America & Middle East & Africa
These regions are gradually adopting AERs, supported by increasing awareness of infection control and targeted healthcare investments.
Conclusion
Growing from USD 697.7 million in 2024 to USD 725.6 million in 2025, and projected to reach USD 1,006.4 million by 2032, the global automated endoscope reprocessors market is on a steady upward trajectory. Rising endoscopy volumes, strict infection control mandates, and expanding healthcare capacity in emerging economies will continue shaping market growth in the coming years.
Segmentation By Type
By Loading Type
By Portability
By Type of Endoscope Reprocessed
By End-user
By Region